Ongoing Pain Signals Rapidly Switch On Spinal Dynorphin Production — But Nerve Cutting Does Not
Chronic nerve constriction and inflammation rapidly upregulated spinal dynorphin gene expression, but clean nerve transection did not — showing the spinal opioid response requires ongoing pain signaling, not just nerve damage.
Quick Facts
What This Study Found
Chronic constriction injury and inflammation both upregulated spinal preprodynorphin mRNA rapidly and sustainably. Complete nerve transection and crush did not.
Key Numbers
How They Did This
Rats underwent sciatic nerve constriction injury, complete transection, crush, or peripheral inflammation. Spinal cord mRNA for preprodynorphin and preproenkephalin was measured at multiple time points.
Why This Research Matters
This study links ongoing pain signals to a specific spinal cord response -- dynorphin production. Since dynorphin can both relieve and worsen pain depending on the context, this finding is important for understanding chronic pain conditions.
The Bigger Picture
This explains why chronic pain conditions with ongoing nerve irritation (like sciatica or inflammatory arthritis) involve different spinal cord changes than clean nerve injuries. The dynorphin upregulation may be both a compensatory pain-relief mechanism and, paradoxically, a contributor to chronic pain sensitization.
What This Study Doesn't Tell Us
Animal study in rats. The chronic constriction injury model is an approximation of human nerve damage. Only spinal cord was examined. Dynorphin's role in pain is complex and context-dependent.
Questions This Raises
- ?Does the spinal dynorphin upregulation help or hurt chronic pain patients?
- ?Could blocking this upregulation improve outcomes for chronic constriction-type injuries?
Trust & Context
- Key Stat:
- Constriction/inflammation: dynorphin up; transection: no change Spinal dynorphin gene expression responds to ongoing pain signals, not to nerve damage itself
- Evidence Grade:
- Preliminary animal study comparing multiple injury models. The differential response across models strengthens the specificity finding.
- Study Age:
- Published in 1991. The role of spinal dynorphin in chronic pain processing is now well-recognized.
- Original Title:
- Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation.
- Published In:
- Brain research, 560(1-2), 186-92 (1991)
- Authors:
- Draisci, G, Kajander, K C, Dubner, R(2), Bennett, G J, Iadarola, M J
- Database ID:
- RPEP-00191
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why does constriction trigger dynorphin but cutting does not?
When a nerve is constricted but not cut, damaged fibers continue sending pain signals to the spinal cord. These ongoing signals drive the dynorphin response. A cleanly cut nerve can't send signals at all.
Is spinal dynorphin good or bad for pain?
It's complex. Initially, dynorphin may help suppress pain. But sustained high levels can paradoxically increase pain sensitivity (hyperalgesia) through mechanisms involving NMDA receptors, potentially worsening chronic pain.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00191APA
Draisci, G; Kajander, K C; Dubner, R; Bennett, G J; Iadarola, M J. (1991). Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation.. Brain research, 560(1-2), 186-92.
MLA
Draisci, G, et al. "Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation.." Brain research, 1991.
RethinkPeptides
RethinkPeptides Research Database. "Up-regulation of opioid gene expression in spinal cord evoke..." RPEP-00191. Retrieved from https://rethinkpeptides.com/research/draisci-1991-upregulation-of-opioid-gene
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.